2024
Ballester J, Quijal-Zamorano M, Méndez Turrubiates RF, Pegenaute F, Herrmann FR, Robine JM, Basagaña X, Tonne C, Antó JM, Achebak H. Heat-related mortality in Europe during the summer of 2022. Nat Med. July 2023;29(7):1857-1866. Epub 2023 Jul 10. Erratum in: Nat Med. 2024 Feb;30(2):603.
Benkirane M, Bonhomme M, Morsy H, Safgren SL, Marelli C, Chaussenot A, Smedley D, Cipriani V, de Sainte-Agathe JM, Ding C, Larrieu L, Vestito L, Margot H, Lesca G, Ramond F, Castrioto A, Baux D, Verheijen J, Sansa E, Giunti P, Haetty A, Bergougnoux A, Pointaux M, Ardouin O, Van Goethem C, Vincent MC, Hadjivassiliou M, Cossée M, Rouaud T, Bartsch O, Freeman WD, Wierenga KJ, Klee EW; Genomic England Research Consortium; Vandrovcova J, Houlden H, Debant A, Koenig M. De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity. Brain 2024. 17:awae193.
Canet G, Gratuze M, Zussy C, Bouali ML, Diaz SD, Rocaboy E, Laliberté F, El Khoury NB, Tremblay C, Morin F, Calon F, Hébert SS, Julien C, Planel E. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer’s disease pathologies in 3xTg-AD mice. Neurobiol Dis 2024. 198:106526.
Carles A, Freyssin A, Perin-Dureau F, Rubinstenn G, Maurice T. Targeting N-methyl-D-aspartate receptors in neurodegenerative diseases. Int J Mol Sci. 2024; 25, 3733.
Carles A,* Hoffmann M,* Scheiner M, Crouzier L, Bertrand-Gaday C, Chatonnet A, Decker M, Maurice T. The selective butyrylcholinesterase inhibitor UW-MD-95 demonstrates symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer’s disease. CNS Neurosci Ther 2024. 30(6):e14814.
Coste J, Robine JM, Van Oyen H, Carcaillon-Bentata L. Metrological performance of the Global Chronic Morbidity Indicator of the Minimum European Health Module and implications for estimates of chronic disease prevalence and socioeconomic gradients. Eur J Public Health. 2024; 29:ckae064.
Cresto N, Givalois L, Badaut J, Janvier A, Genin A, Audinat E, Brewster AL, Marchi N. Bursts of brain erosion: seizures and age-dependent neurological vulnerability. Trends in Molecular Medicine 2024. S1471-4914(24)00304-6.
Crouzier L, Meunier J, Carles A, Morilleau A, Vrigneau C, Schmitt M, Bourguignon JJ, Delprat B, Maurice T. Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties. Phytother Res 2024. 38(2):694-712.
Meslé F, Vallin J, Camarda C-J, Caporali A, Poniakina S, Toussaint L, Robine J-M. Living beyond age 105: When the improbable becomes reality. Population & Societies, 621, April 2024
Freyssin A, Carles A, Guehairia S, Rubinstenn G, Maurice T. Fluoroethylnormemantine (FENM) provides synergistic protection when combined with a sigma-1 receptor agonist in a mouse model of Alzheimer’s disease. Neuropharmacology 2024. 242:109733.
Freyssin A, Carles A, Moha B, Rubinstenn G, Maurice T. Long-term treatment with fluoroethylnormemantine (FENM) alleviated memory deficits, amyloid pathology, and microglial reaction in APP/PS1 mice. ACS Pharmacol Transl Sci 2024. 7(12):4069-4082
García-Pupo L, Crouzier L, Bencomo-Martínez A, Meunier J, Morilleau A, Delprat B, Sablón Carrazana M, Menéndez Soto del Valle R, Maurice T,* Rodríguez-Tanty C.* Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein. Acta Pharmaceutica Sinica B 2024. 14(10):4345-4359.
Gerber YN,Perrin FE. In vivo astrocyte reprogramming following spinal cord injury.Neural Regen Res2024;19, 487–488.
Kacher R, Lejeune FX, David I, Boluda S, Coarelli G, Leclere-Turbant S, Heinzmann A, Marelli C, Charles P, Goizet C, Kabir N, Hilab R, Jornea L, Six J, Dommergues M, Fauret AL, Brice A, Humbert S, Durr A. CAG repeat mosaicism is gene-specific in spinocerebellar ataxias. Am J Hum Genet 2024. 2;111(5):913-926.
Marelli C, Ramond F, Vignal C, Blanchet C, Frost S, Hao Q, Bocquet B, Nadjar Y, Leboucq N, Taieb G, Benkirane M, Hersent C, Koenig M, Meunier I. Phenotypic variability associated with dominant UCHL1 mutations: a report on three families with optic atrophy and ataxia. J Neurol 2024. 271(9):6038-6044.
Méreaux JL, Davoine CS, Pellerin D, Coarelli G, Coutelier M, Ewenczyk C, Monin ML, Anheim M, Le Ber I, Thobois S, Gobert F, Guillot-Noël L, Forlani S, Jornea L, Heinzmann A, Sangare A, Gaymard B, Guyant-Maréchal L, Charles P, Marelli C, Honnorat J, Degos B, Tison F, Sangla S, Simonetta-Moreau M, Salachas F, Tchikviladzé M, Castelnovo G, Mochel F, Klebe S, Castrioto A, Fenu S, Méneret A, Bourdain F, Wandzel M, Roth V, Bonnet C, Riant F, Stevanin G, Noël S, Fauret-Amsellem AL, Bahlo M, Lockhart PJ, Brais B, Renaud M, Brice A, Durr A. Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. EBioMedicine. 2024; 99:104931.
Micheau J, Catheline G, Barse E, Hiba B, Marcilhac A, Allard M, Platt B, Riedel G. PLB2Tau mice exhibit deficits in novel and temporal object recognition and show corresponding features on brain MRI. Brain Res Bull2024. 220:111161.
Notartomaso S, Antenucci N, Mazzitelli M, Rovira X, Boccella S, Ricciardi F, Liberatore F, Gomez-Santacana X, Imbriglio T, Cannella M, Zussy C, Luongo L, Maione S, Goudet C, Battaglia G, Llebaria A, Nicoletti F, Neugebauer V. A ‘double-edged’ role for type-5 metabotropic glutamate receptors in pain revealed by light-sensitive drugs. eLife 2024. 13:e94931.
Otaegui L, Lehoux J, Martin L, Givalois L, Durand T, Desrumaux C, Crauste C. Overview of alkyl quercetin lipophenol synthesis and its protective effect against carbonyl stress involved in neurodegeneration. Org Biomol Chem. 2024; 22:2877-2890.
Patergnani S, Bataillard MS, Danese A, Alves S, Cazevieille C, Valero R, Tranebjaerg L, Maurice T, Pinton P, Delprat B, Richard EM. The Wolfram-like variant WFS1E864K destabilizes MAM and compromises autophagy and mitophagy in humans and mice. Autophagy. 2024 23:1-12.
Poulen G, Gélisse P, Chan-Seng E, Moser PO, Genton P, Crespel A, Coubes P. Neuromodulation of the globus pallidus internus (GPi) is not effective in controlling myoclonus in Unverricht-Lundborg disease. Mov Disord. 2024 9:2354-2364
Poulen G, Chan-Seng E, Sanrey E, Coubes P. A case of successful pallidal deep brain stimulation in ANO3 dystonia. Mov Disord. 2024; 39:1071-1072
Poulen G, Mercedes-Alvarez B, Rigau V, Coubes P. Bilateral periventricular nodular heterotopia and cortical dysplasia due to a filamin 1 gene mutation: An invasive EEG study and histopathological analysis. Epileptic Disord 2024. 26(2):240-243.
Poulen G, Perrin FE. Advances in spinal cord injury: insights from non-human primates. Neural Regeneration Research. 2024;19:2354–2364.
Quijal-Zamorano M, Petrova D, Martínez-Solanas È, Herrmann FR, Rodó X, Robine JM, Marí-Dell’Olmo M, Achebak H, Ballester J. Assessment of the forecasting skill of an operational continental heat-cold-health forecasting system: New avenues for health early warning systems. Sci Adv. 2024 Nov 15;10(46):eado5286
Richard ÉM, Delprat B. Local administration of an AAV-TMPRSS3 vector in aged mice corrects progressive hearing loss in a mouse model of DFNB8-associated deafness [Local administration of an AAV-TMPRSS3 vector in aged Tmprss3 mutant mice with progressive deafness restores hearing]. Med Sci (Paris) 2024. 40(5):402-404.
Tarot P,Lasbleiz C,Liévens JC. The NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality.Neural Regen Res. 2024;19:1006–1012.
Veyrunes F, Perez J, Heitzmann LD, Saunders PA, Givalois L. Hormone profiles of the African pygmy mouse *Mus minutoides*, a species exhibiting XY female sex reversal. J Exp Zool A Ecol Integr Physiol. 2024; 341:130-137.